Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Intanwijaya Internasional Tbk (INCI) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Intanwijaya Internasional TbkTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Intanwijaya Internasional Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 24.2K 24h volume), while Intanwijaya Internasional Tbk trades at Rp655 (market cap 133.94B, 3.2K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.3× Intanwijaya Internasional Tbk's market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (24.2K versus 3.2K). Which is the better fit depends on your goals.

DGNSINCI
Market Cap
308B133.94B
Volume
24.2K3.2K
Lot
24232
Turnover
5.5M2.08M
Average Price
227.27650.16
Value
5.5M2.08M
Indicative Equilibrium Price
230
Indicative Equilibrium Volume
110

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
INCI
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Intanwijaya Internasional Tbk

PT Intanwijaya International Tbk (the Company) formerly named as PT Intan Wijaya Chemical Industry Tbk, was established in Jakarta based on the Notarial Deed No. 64 of Jony Frederik Berthold Tumbelaka Sinjal, S.H., dated November 14, 1981.The company's business field in in the Formaldehyde and Formaldehyde Resin Industries with the capacity of 96.000 metrics tons per annum in the form of liquid and 7.000 metric tons per annum in the form of powder and Hexamine 6.000 metric tons per annum.

Read more on INCI